BNP Paribas head of equity cash trading Darren Wolfberg breaks down where the big-money players are investing.
FBN’s Liz MacDonald on latest BNP news.
FBN’s Liz MacDonald on BNP ’s settlement over sanctions violations.
Schulte, Roth & Zabel managing partner Paul Roth weighs in on the U.S. corporate tax rate.
Wall Street Journal editor-in-chief Gerard Baker on lawmakers possibly leaking info ahead of health-care policy change.
Former SEC chairman Harvey Pitt, former SEC attorney Elizabeth Nowicki, and Florida Bankers Association CEO Alex Sanchez discuss the bank regulatory environment.
FBN’s Maria Bartiromo breaks down what you need to know.
FBN’s Liz MacDonald on the bull-run in government fines.
FBN’s Liz MacDonald, Sandra Smith and Maria Bartiromo discuss BNP Paribas ’ $10B fine.
Good360 chairman Carly Fiorina weighs in on the economy.
FBN’s Liz MacDonald on the French President’s letter to Obama on BNP .
Concerned Veterans for America’s Jessie Jane Duff, Accent Asset Management CEO Scott Martin and FOXBusiness.com reporter Kate Rogers on the potential fine facing French bank BNP Paribas and the big potential Medicare savings by using less expensive medications.
FBN’s Liz MacDonald on France’s reaction to BNP Paribas ’ possible $10B U.S. fine.
RDQ Economics chief economist John Ryding and BNP Paribas head of equity cash trading Darren Wolfberg give their outlooks for the Fed and markets.
FBN’s Liz MacDonald on new reports that regulators are going after two new banks for violating U.S. sanctions.
Bernstein equity research analyst Brad Hintz breaks down why he downgraded Goldman Sachs from outperform to market perform.
IG market analyst Chris Beauchamp on the European markets.
South Texas Money Management president Jim Kee names stocks with great cashflow.
Wall Street Journal editor-in-chief Gerard Baker discusses the markets and economy.
FBN’s Jo Ling Kent on news BNP Paribas is close to settling a long-running U.S. investigation into its alleged violation of U.S. sanctions.